Open AccessRamucirumab Extends Survival in Advanced Esophagogastric Cancer—Benefit May be Similar to That for Chemotherapy
Author(s) -
Rabiya S. Tuma
Publication year - 2013
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000430611.08782.97
Subject(s) - ramucirumab , medicine , apatinib , placebo , cancer , regimen , adverse effect , oncology , gastroenterology , surgery , alternative medicine , pathology